Literature DB >> 12003696

Drug overuse and rebound headache.

Stephen D Silberstein1, Dongmei Liu.   

Abstract

The overuse of acute medications in patients who are headache-prone poses a great challenge to headache management. Medication overuse-induced headache represents one of the most common iatrogenic disorders. It is the reason that most patients visit headache subspecialty clinics worldwide and often is the cause of an intractable or worsening headache in primary headache sufferers. The recent development of acute headache medications, especially the triptans, has provided increased migraine relief; however, the incidence of triptan-overuse headache has also increased. Awareness of medication overuse-induced headache and familiarity with the diagnosis and the treatment of this disorder are important to physicians who treat patients with headache.

Entities:  

Mesh:

Year:  2002        PMID: 12003696     DOI: 10.1007/s11916-002-0041-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  37 in total

Review 1.  Analgesic rebound headache.

Authors:  A M Rapoport
Journal:  Headache       Date:  1988-11       Impact factor: 5.887

2.  Analgesic-induced chronic headache: long-term results of withdrawal therapy.

Authors:  H C Diener; J Dichgans; E Scholz; S Geiselhart; W D Gerber; A Bille
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

3.  Time required for improvement of an analgesic rebound headache.

Authors:  J S Warner
Journal:  Headache       Date:  1998-03       Impact factor: 5.887

4.  Paradoxical effects of frequent analgesic use.

Authors:  L Kudrow
Journal:  Adv Neurol       Date:  1982

Review 5.  Drug-induced headache.

Authors:  N T Mathew
Journal:  Neurol Clin       Date:  1990-11       Impact factor: 3.806

6.  Repetitive intravenous dihydroergotamine as therapy for intractable migraine.

Authors:  N H Raskin
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

7.  Withdrawal syndrome after the double-blind cessation of caffeine consumption.

Authors:  K Silverman; S M Evans; E C Strain; R R Griffiths
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

8.  Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE.

Authors:  S D Silberstein; J R Silberstein
Journal:  Headache       Date:  1992-10       Impact factor: 5.887

9.  Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches.

Authors:  C Baumgartner; P Wessely; C Bingöl; J Maly; F Holzner
Journal:  Headache       Date:  1989-09       Impact factor: 5.887

Review 10.  Chronic headache syndromes.

Authors:  J R Saper
Journal:  Neurol Clin       Date:  1989-05       Impact factor: 3.806

View more
  4 in total

Review 1.  Secondary headaches.

Authors:  Jack Gladstein
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 2.  Tension-type headache with medication overuse: pathophysiology and clinical implications.

Authors:  Teshamae S Monteith; Michael L Oshinsky
Journal:  Curr Pain Headache Rep       Date:  2009-12

3.  Drug dependence associated with triptans and ergot derivatives: a case/non-case study.

Authors:  Frédérique Beau-Salinas; Annie Pierre Jonville-Béra; Haware Cissoko; Lamiae Bensouda-Grimaldi; Elisabeth Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2009-12-19       Impact factor: 2.953

Review 4.  Management of chronic daily headache in children and adolescents.

Authors:  Kenneth J Mack; Jack Gladstein
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.